author-photo

Shinji Takagi

Takeda Pharmaceutical Company

13

Papers

249

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress response.

2020 Nature Communications
Show All
- Source
- Cite
- Save
Citations (35)
Author Correction: Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress response

2020 Nature Communications
Show All
- Source
- Cite
- Save
Citations (2)
Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress response

2018 bioRxiv
Show All
- Source
- Cite
- Save
Citations (3)
LSD1 Inhibitor T-3775440 Inhibits SCLC Cell Proliferation by Disrupting LSD1 Interactions with SNAG Domain Proteins INSM1 and GFI1B

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (34)
Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication

2017
Show All
- Source
- Cite
- Save
Citations (19)
A novel LSD1 inhibitor T-3775440 disrupts GFI1B-containing complex leading to transdifferentiation and impaired growth of AML cells.

2017 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (56)
HER2 and HER3 cooperatively regulate cancer cell growth and determine sensitivity to the novel investigational EGFR/HER2 kinase inhibitor TAK-285

2014
Show All
- Source
- Cite
- Save
Citations (16)
Antitumor Activity of TAK-285, an Investigational, Non-Pgp Substrate HER2/EGFR Kinase Inhibitor, in Cultured Tumor Cells, Mouse and Rat Xenograft Tumors, and in an HER2-Positive Brain Metastasis Model.

2013 Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (14)
Structure-Based Approach for the Discovery of Pyrrolo[3,2-d]pyrimidine-Based EGFR T790M/L858R Mutant Inhibitors

2013 ACS Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (63)
HER2 and HER3 cooperatively regulate tumor cell growth and determine sensitivity to the HER kinase inhibitor TAK-285.

2009 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)